|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Nonemployee Director Stock Option (Right to Buy) | $ 72.98 (3) | 04/26/2005 | A | 2,500 | 04/26/2006(4) | 04/26/2015 | Common Stock | 2,500 | $ 0 | 2,500 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
HERBERT GAVIN S 2525 DUPONT DRIVE IRVINE, CA 92612 |
X |
By: Matthew J. Maletta, Attorney-in-Fact | 04/27/2005 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Transfer of 1,800 shares held directly by the reporting person to the Herbert Family Trust. |
(2) | Shares held by the Herbert Family Trust. Reporting person is trustee and beneficiary of this trust and has the power to revoke without another's consent. (Includes an aggregate of 306 shares held by J. Gleis, LLC. The Herbert Family Trust holds a 1% interest in GHH Capital, LLC, which beneficially owns all the shares held by J. Gleis, LLC. The reporting person disclaims beneficial ownership of the shares held by J. Gleis, LLC, except to the extent, if any, that a pecuniary interest is ultimately realized.) |
(3) | The per share exercise price is the closing price of Allergan common stock as of April 25, 2005, rounded upwards to three decimals. |
(4) | Option is fully vested and exercisable on the one year (1) year anniversary of its grant. |